Loading company…
Zogenix develops treatments for central nervous system disorders and pain.
Zogenix is a biotechnology company that develops treatments for central nervous system disorders and pain. Its products include ZX008, low-dose fenfluramine, for Dravet syndrome and Lennox-Gastaut syndrome. Founded in 2006, the company is based in Emeryville, US, and is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in